Cyclerion Therapeutics, Inc. (CYCN) › Operating IncomeCyclerion Therapeutics, Inc. (CYCN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$115.25M2019: -$125.04M2020: -$81.27M2021: -$55.20M2022: -$18.54M2023: -$12.95M2024: -$3.63M2025: -$4.97M-$4.97M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$4.97M-37.1%2024-$3.63M+72.0%2023-$12.95M+30.1%2022-$18.54M+66.4%2021-$55.20M+32.1%2020-$81.27M+35.0%2019-$125.04M-8.5%2018-$115.25M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share